A treatment trial of acupuncture in IBS patients
- PMID: 19455132
- PMCID: PMC2694961
- DOI: 10.1038/ajg.2009.156
A treatment trial of acupuncture in IBS patients
Abstract
Objectives: This study aimed to compare the effects of true and sham acupuncture in relieving symptoms of irritable bowel syndrome (IBS).
Methods: A total of 230 adult IBS patients (75 % females, average age: 38.4 years) were randomly assigned to 3 weeks of true or sham acupuncture (6 treatments) after a 3-week "run-in" with sham acupuncture in an "augmented" or "limited" patient-practitioner interaction. A third arm of the study included a waitlist control group. The primary outcome was the IBS Global Improvement Scale (IBS-GIS) (range: 1 - 7); secondary outcomes included the IBS Symptom Severity Scale (IBS-SSS), the IBS Adequate Relief (IBS-AR), and the IBS Quality of Life (IBS-QOL).
Results: Although there was no statistically significant difference between acupuncture and sham acupuncture on the IBS-GIS (41 vs. 32 % , P = 0.25), both groups improved significantly compared with the waitlist control group (37 vs. 4 % , P = 0.001). Similarly, small differences that were not statistically significant favored acupuncture over the other three outcomes: IBS-AR(59 vs. 57 % , P = 0.83), IBS-SSS (31 vs. 21 % , P = 0.18), and IBS-QOL (17 vs. 13 % , P = 0.56). Eliminating responders during the run-in period did not substantively change the results. Side effects were generally mild and only slightly greater in the acupuncture group.
Conclusions: This study did not find evidence to support the superiority of acupuncture compared with sham acupuncture in the treatment of IBS.
Conflict of interest statement
No Conflicts of Interest Exist
Figures
Comment in
-
Ideas on trial design in acupuncture for IBS.Am J Gastroenterol. 2010 Mar;105(3):699. doi: 10.1038/ajg.2009.647. Am J Gastroenterol. 2010. PMID: 20203649 No abstract available.
-
Acupuncture for irritable bowel syndrome: sham or the real deal?Gastroenterology. 2010 Jul;139(1):348-50; discussion 350-1. doi: 10.1053/j.gastro.2010.05.033. Gastroenterology. 2010. PMID: 20639088 No abstract available.
References
-
- Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491. - PubMed
-
- Saito YA, Schoenfeld P, Locke GR., 3rd The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol. 2002;97:1910–1915. - PubMed
-
- Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654–660. - PubMed
-
- Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics. 2006;24:21–37. - PubMed
-
- Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther. 2003;18:671–682. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials